Login
$AVAH
$11.72 +$0.08 (0.73%) Live

$AVAH SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 8-K: Regulation FD Disclosure

Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a sol...

12 Nov 2026 10-Q
12 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Atlanta, Georgia (November 12, 2026) – Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial re...

10 Nov 2026 SCHEDULE 13G/A
05 Oct 2026 Form 4: Stewart Deborah, SVP, Chief Accounting Officer

Received 75,000 shares as a grant or award

02 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

On October 1, 2026, Steven E. Rodgers, a Class II director of Aveanna Healthcare Holdings Inc. (the "Company"), notified the Company of his decision to resign from the Company's Board of Directors, effective immediately. Mr. Rodgers‘ dec...

09 Sep 2026 144
27 Aug 2026 144
24 Aug 2026 Form 4: J.h. Whitney Equity Partners VII, Llc, 10% owner

Sold 12,496,077 shares ($144M) · Sold 2,250,000 shares ($25.9M)

24 Aug 2026 Form 4: Williams Robert M Jr, 10% owner

Sold 14,500,002 shares ($167M) · Sold 2,250,000 shares ($25.9M)

24 Aug 2026 Form 4: Vigano Paul R, 10% owner

Sold 14,500,002 shares ($167M) · Sold 2,250,000 shares ($25.9M)

24 Aug 2026 Form 4: Windley Rodney D, Director

Sold 180,000 shares ($2.07M)

24 Aug 2026 Form 4: Shaner Jeff, Chief Executive Officer

Sold 90,000 shares ($1.04M)

24 Aug 2026 Form 4: Reisz Edwin C., Chief Administrative Officer

Sold 50,000 shares ($575K)

24 Aug 2026 8-K: Other Events

The stockholders named in Schedule II attached hereto (the “Selling Stockholders”) of Aveanna Healthcare Holdings Inc., a Delaware corporation (the “Company”) propose to sell an aggregate of 15,000,000 shares (the “Firm Stock”) of the Co...

24 Aug 2026 424B4
20 Aug 2026 424B4
13 Aug 2026 10-Q
13 Aug 2026 8-K: Regulation FD Disclosure

Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a sol...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support